Summary of Role
We are looking to appoint an enthusiastic Digital Content Writer to work within the Drug Development Unit at the ICR. This is an exciting opportunity to help shape and showcase the Unit’s profile across digital platforms by creating engaging, impactful, and accessible content. The post holder will work closely with senior management, researchers, and wider teams to develop contents that highlight our research, achievements, and commitment to patients.
The post holder will play key role in ensuring that all online and offline content is aligned, consistent, and designed to connect with diverse audiences. This role is ideal for a creative communicator who is passionate about science, innovation, and making a positive difference through digital media.
Key Requirements
Applicants should have digital media expertise, excellent writing and editing skills, and have an ability to write engaging content for different audiences on various digital platforms.
They should be familiar with software and digital tools used for content creation. The post holder will need to be highly organised with their work and be able to work in a flexible manner.
This exciting position has arisen within the Drug Development Unit, as we are a rapidly expanding, world class Phase 1 clinical trials unit and we need showcase our Unit’s work to our stakeholders.
To apply for this post, please submit an online application including a supporting statement, detailing reasons why you are applying for the post and include your CV. We encourage all applicants to access the job pack attached for more detailed information regarding this role.
Due to the high volumes of applications that we receive, we reserve the right to close the advert before the published closing date, once we have received a sufficient number applications. Therefore, we advise that you to submit your application, as early as possible to avoid disappointment.
Department Information:
The Drug Development Unit, (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, is a world-leading centre for early-phase oncology trials, translating cutting-edge science into first-in-human clinical trials.
Through close integration of laboratory and clinical expertise, the Unit supports the functions of sponsoring early phase trials through Investigator Initiated Trials Team, as well as delivers academic and industry sponsored trials.
Our mission is to fast-track the development of anti-cancer drugs, designed and synthesised at The ICR, or developed by CRUK scientists, or developed by industry collaborators, in order to rapidly impact the care of cancer patients. The DDU has been involved in the development of many hundreds of novel agents including several practice-changing cancer drugs.
The DDU is one of the Experimental Cancer Medicine Centres in the UK, part of the CRUK Convergence Science Centre and the Early Phase Drug Development Theme within the ICR-RM NIHR Biomedical Research Centre (BRC). The DDU has multiple academic and industry collaborations both nationally and internationally, to optimally serve our patients. The Unit is led by Professor Johann de Bono and Professor Udai Banerji.